Company intelligence / Profile preview

Protarga, Inc.

King of Prussia, Pennsylvania, United Statesprotaratx.com ↗
Ownership
Private
Development stage
Clinical
01

Overview

Protarga was a clinical-stage pharmaceutical company focused on developing targeted therapies for cancer and other serious diseases using its proprietary fatty acid vector technology. Its lead program was a paclitaxel-fatty acid conjugate that advanced to late-stage clinical trials. The company collaborated with the National Cancer Institute and had several programs in preclinical or early development at the time of its acquisition in 2003.

Therapeutic areas
OncologyMetabolic DisordersInfectious Diseases
Modalities
Small molecules (notably fatty acid-drug conjugates)Chemical drugs
Industry
Biotech
02

Drug pipeline

1 asset

Taxoprexin

Phase 2
Indications
Cancer
03

Partnerships

National Cancer Institute (NCI) – collaboration on anti-cancer compound development using Protarga’s targeting technology

Beyond the preview

Go deeper on Protarga, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protarga, Inc..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call